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pected, property of uretupamine is its ability to inhibit aProtein Modulators Made to Order
particular function of Ure2p without affecting the protein
globally. Ure2p regulates gene expression in response
to nitrogen and carbon source quality [3–5]. In the pres-
Small molecules were created by diversity-oriented ence of high-quality nitrogen and carbon sources, Ure2p
synthesis and subsequently subjected to microarray- inhibits the transcriptional activators Gln3 and Nil1 that
based screening for their ability to bind a protein of are responsible for the expression of genes regulating
interest. This general two-step method proved power- nitrogen and carbon metabolism. Upon glucose depriva-
ful in generating highly specific modulators of protein tion or a switch to a poor nitrogen source, Ure2p sup-
function. pression is removed, which leads to Gln3 and Nil1 acti-
vation and subsequent gene expression. Interestingly,
For several decades, natural and synthetic small mole- uretupamine treatment activated only a subset of genes
cules have provided powerful biological probes to delin- that are controlled by Ure2p—the same set of genes
eate protein functions and regulatory mechanisms of that are upregulated upon glucose removal. Previously,
physiological systems. However, small molecules with the same authors proposed that Ure2p might differen-
high specificity toward given proteins have been hard tially control responses to nitrogen and carbon source
to come by, and the traditional approach of pursuing via Gln3 and Nil1, respectively [5, 6] (Figure 2). Now
biologically active natural products often takes years to taking advantage of the selectivity of uretupamine, they
identify each cellular target. With the completion of the are able to confirm this hypothesis by a combination
draft human genome sequence, the pressing need to of genetic manipulation, whole-genome profiling, and
study protein functions has put small molecules on cen- biochemical studies. Here, the power of chemical genet-
ter stage. In demand are more efficient and systematic ics is demonstrated at its fullest. Uretupamine is capable
methods to identify specific molecular probes. A recent of modulating Ure2p function at a level that genetic
report by Kuruvilla et al. in Nature [1] elegantly demon- deletion of Ure2p cannot, and it is comparable to func-
strates the power of such a method. A library of small tionally selective Ure2p mutants, which are not yet
molecules was generated by diversity-oriented synthe- known.
sis [2] and microarrayed on glass slides. Screening of This exquisite specificity of uretupamine is not so sur-
this library led to the discovery of a specific inhibitor— prising if one recalls the case of the bacterial macrolide
named uretupamine —for the yeast protein Ure2p, a rapamycin, which has served as one of the paradigms
central regulator of nutrient-dependent gene expres- of small-molecule probes [7]. Coincidentally, the targets
sion. Initial screening of 3780 compounds for their ability of rapamycin (Tor1/2p) in yeast are upstream regulators
to bind a fluorescently labeled Ure2p yielded eight can- of Ure2p, and rapamycin has been instrumental in help-
didates, of which one compound (uretupamine A) (Figure ing dissect nutrient-response pathways (e.g., [3, 5, 6]).
1) specifically inhibited Ure2p function in cellular re- In addition to regulating transcription, Tor2p controls a
porter assays. Upon further analyzing the structure and multitude of cellular functions in response to nutrient
activity of this compound, the researchers were able availability; such functions include actin cytoskeleton
to synthesize a more potent derivative (uretupamine B) reorganization [8]. Rapamycin, in complex with its cellu-
(Figure 1) with increased solubility in cell media. The lar receptor FKBP, directly binds the Tor proteins and
striking specificity of uretupamine was demonstrated inhibits Tor1/2p’s ability to regulate transcription via
by whole-genome transcriptional profiling; a subset of Ure2p and other proteins, but it has no effect on actin
genes known to be suppressed by Ure2p was signifi- cytoskeleton reorganization [9], which is mediated by
cantly upregulated by uretupamine, but they were unaf- ROM2 and its effectors downstream of Tor2p ([8]; Figure
fected by the compound in a yeast strain in which Ure2p 2). Thus, there is a clear parallel between rapamycin and
was deleted. uretupamine in their specificity. From a protein biochem-
istry point of view, such selectivity of small moleculesPerhaps the most remarkable, and somewhat unex-
Figure 1. Structure of Uretupamine A and B
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Figure 2. Selective Inhibitors
By directly binding to their targets, uretupam-
ine and rapamycin inhibit only one of two
functions of Ure2p and Tor2p, respectively.
For simplicity, other pathways regulated by
Tor2p are omitted.
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